Vorinostat, a Histone Deacetylase Inhibitor, as a Potential Novel Treatment for Psoriasis

0
22
The authors investigated the efficacy of the histone deacetylase inhibitor, Vorinostat, in targeting hyperproliferation and impaired apoptosis in psoriatic skin.
[Experimental Dermatology]

Sorry, but the selected Zotpress account can't be found.

Abstract